More than 650,000 working Americans are going to get cancer this year and most of them will return to work. That means employers are going to have to figure out a way to deal with the disease as well. Hillary Wicai reports.
The FDA today approved over-the-counter sales of Plan B, ending a long political debate. But what financial impact will it have? Host Kai Ryssdal talks with Susan Dudley of the National Research Center for Women and Families.
A biotech company claims it can create embryonic stem cells without destroying embryos. But that still might not be enough to entice investors. Helen Palmer reports.
About 4,500 women have filed lawsuits against Wyeth for failing to warn them of cancer risks from its menopause drug Prempro that were found in a 2001 study. The first of those cases goes to trial tomorrow. Helen Palmer reports.
Drug maker Bristol Myers Squibb is in court trying to stop a Canadian company from selling a generic version of its blockbuster blood-thinning drug. Helen Palmer reports.
Two drug companies are going to court today to try to stop a Canadian pharmaceutical company from selling a generic of the No. 2 top-selling prescription drug: blood-thinner Plavix. Ashley Milne-Tyte reports.
The cost to care for stroke victims is expected to reach $2.2 trillion over the next 45 years. Doctors are calling for more government cash to halt what they call an impending epidemic. Helen Palmer reports.
You've heard of the income gap between rich and poor. A new study looks at the health care gap — and finds it's not just the poor at a disadvantage. Corinna Wu reports.
